Abstract: The devices and methods described herein relate to improved structures for removing obstructions from body lumens. Such devices have applicability in through-out the body, including clearing of blockages within the vasculature, by recanalizing or removing the obstruction within the body lumen.

Abstract: Described are apparatus and methods for preventing sperm passage through a reproductive structure of a patient, and also for subsequently reversing the preventative measure in order to restore fertility to the patient. In some embodiments, the apparatus includes an elongate member arranged to form a frame having a distal and proximal opening and configured to be positioned within a lumen of the reproductive structure. The apparatus may also have a flow reducing member coupled to the frame such that when the frame is positioned within the lumen, the flow reducing member substantially impedes, reduces, or totally obstructs passage of sperm through the lumen.

Abstract: A stent having a tubular lattice structure includes lattice elements, webs (10), and cells (11) delimited by the lattice elements. The lattice structure is transferred into a compressed state having a relatively smaller cross-sectional diameter and into an expanded state having a relatively larger cross-sectional diameter. Flexible contact elements (12) are associated with the lattice elements. The contact elements are adapted for transferring radial forces onto a vessel wall (20) and extending on the outer circumference of the lattice structure substantially in the longitudinal direction of each associated lattice element. The contact elements (12) are wider in each case than the associated lattice elements, at least in sections.

Abstract: The present invention provides a method to transfer block copolymers from water immiscible organic phase to aqueous phase using a phase transfer agent. At higher concentrations, micellar networks of the block copolymers were obtained in the aqueous solution that can be coated onto a variety of substrates. Block copolymer films showed very good antifouling properties. The phase transferred block copolymers can be used to synthesize encapsulated nanoparticle aggregates for biodiagnostic imaging applications. The phase transferred block copolymer micelles can be used to encapsulate active compounds. The invention has applications in drug delivery, crop protection, and medical device coating.

Abstract: A stent may include a connector having a first portion, a second portion, and a third portion positioned between the first and second portions. The connector may be configured to interconnect axially adjacent stent segments. The connector may be further configured such that the third portion severs in response to a threshold amount of axial force, axial foreshortening, and/or cyclic loading or fatigue, in order to predispose the severance of one or more pre-configured connectors in a controlled manner to minimize any potential harm to the surrounding vasculature of a patient.

Abstract: A pattern is used to form a stent scaffold from a polymeric precursor tube having a particular outer diameter. A new pattern can be derived from a base pattern, wherein the new pattern can be used to form a stent scaffold from a precursor tube having an outer diameter ODPR smaller than that needed for the base pattern. The new pattern can be derived by determining the shape of a stent scaffold, having the base pattern, after having been radially compressed to ODPR. The radially compressed shape is used to design the new pattern, which is applied to a precursor tube having an outer diameter ODPR. The new pattern can have a plurality of W-shaped closed cells, each W-shape closed cell bounded by struts oriented in such a way to form interior angles from about 80 degrees to about 95 degrees between every two adjacent struts.

Abstract: Radially expandable implantable medical devices, such as stents, with locking elements are disclosed.

Abstract: A stent including a plurality of loop stents connected by struts so that it bends uniformly as a whole. A stent A including a plurality of loop stents 2 connected by a plurality of struts 3, the loop stents 2 each formed of a stent main wire 1 folded into a zigzag shape and joined at its ends, wherein the bending strength of each strut 3 is larger than the bending strength of the stent main wire 1.

Abstract: The endovascular graft includes a tubular structure having a first end and a second end. The tubular structure has a wall which defines a lumen between the first and second ends. A fenestration is located between the first and second ends to extend through the wall of the tubular structure. A sealing ring is circumferentially disposed within or on, including without limitation secured to, the tubular structure. The sealing ring is adjacent to the fenestration. The sealing ring may be inflatable.

Abstract: A medical device with a radially compressible and expandable lattice structure (10) contains at least one closed cell (15) delimited in each case by four webs (11, 12, 13, 14) coupled to one another in one piece, of which at least one web (11, 12, 13, 14) is embodied as a stabilisation web (11, 13) with a first web width b1 and at least two further webs (11, 12, 13, 14) are embodied as connecting webs (12, 14) with a second web width b2, wherein the connecting webs (12, 14) are arranged inside the cell (15) so that they lie parallel opposite one another and are connected to one another by the stabilisation webs (11, 13) and wherein the ratio b1/b2 between the first web width b1 and the second web width b2 is at least 1.2.

Abstract: A luminal cavity closing device can include a flexible shaft, a lid member, and a detachment mechanism. The flexible shaft extends in an axial direction. The lid member which is attached to a distal end of the shaft, can be rotated according to a torque transmitted from the shaft. Thus, a lock section can be thrust into a periphery of an opening of a luminal cavity formed in a living body lumen, to thereby lock the lid member to the periphery. The detachment mechanism can be configured to detachably attach the lid member to the shaft. The torque can be transmitted to the lid member, and the shaft can be detached from the lid member by the detachment mechanism while the lid member is locked to the periphery of the opening of the luminal cavity.

Abstract: The present invention provides methods and devices for placement of a stent in a bifurcation or ostial lesion. The stent comprises a main body and a flaring portion. The main body is designed to expand and support a main vessel of the bifurcation and defines a main body axis. The flaring portion is disposed on a side of the main body and is adapted to flare radially and offset the main body axis in response to expansion of the main body. The flaring portion comprises at least one distal wing and at least one proximal wing. Each wing is aligned along the main body axis. The at least one proximal wing is longer than the at least one distal wing, providing greater coverage of the proximal side of the side vessel than on the distal surface of the side vessel.

Abstract: The invention relates to a stent comprising terminal anchoring elements. Said stent (10) is provided with a tubular wall that extends along a longitudinal, flexible tubular axis (26), is formed from a flexible grid structure, and has tube ends (20) lying on opposing axis ends. Said wall consists of annular wall segments (11) that are lined up along the axis and are interconnected by means of connection segments (12). The annular wall segments (11) contain wall elements (14, 15) having an elastic structure.

Abstract: A stent has circular bodies having a wavy-line pattern and arranged side-by-side and coiled elements 15 arranged between the circular bodies that are adjacent and extending in a spiral manner, and apices on opposite sides of the wavy-line pattern of the circular bodies that are adjacent are connected by way of the coiled elements 15. A knob portion 19 is formed at each apex of the wavy-line pattern, and the knob portion 19 includes an extension portion 19a extending in the axis direction and a semicircle portion 19b formed at a tip of the extension portion, and the coiled element 15 is connected with the knob portion 19. A slit is formed at a part of the extension portion 19a of the knob portion 19, and the slit 21 extends in the axis direction from an inner peripheral portion at the apex of the wavy-line pattern of the circular body.

Abstract: A stent in a non-expanded state has a first and second expansion column, each consisting of a plurality of expansion strut pairs. An expansion strut pair includes a first expansion strut, a second expansion strut and a joining strut that couples the first and second expansion struts at one end. A connecting strut column, formed of a plurality of connecting struts couples the first and second expansion columns. Connecting struts include a proximal section, a distal section and an intermediate section. The proximal section is coupled to the corner of an expansion strut pair of the first expansion column, and the distal section is coupled to the joining strut of an expansion strut pair of the second expansion column intermediate the expansion strut pair first corner and the expansion strut pair second corner.

Abstract: The preferentially electropolished stent system and method of manufacture includes a stent delivery system including a catheter; a balloon operably attached to the catheter; and a stent disposed on the balloon. The stent includes an elongate body having an abluminal surface and a luminal surface; wherein the abluminal surface has an abluminal average roughness less than or equal to 0.030 microns; and the luminal surface has at least one rough portion having an luminal average roughness greater than or equal to 0.036 microns.

Abstract: A vascular endoprosthesis (100, 200, 300, 400, 500, 600) includes a radially-expandable first segment and a radially expandable second segment. The vascular endoprosthesis further includes first and second coupling elements. The first coupling element extends from the proximal end of the first segment toward the distal end of the second segment, and the second coupling element extends from the distal end of the second segment toward the proximal end of the first segment. The first and second coupling elements cooperate one with another to couple the first and second segments together when the vascular endoprosthesis is in a delivery configuration and to decouple the first and second segments when the vascular endoprosthesis is in a deployed configuration.

Abstract: A stent and a method for manufacturing a stent are provided. The stent includes a first ring having a plurality of peaks and a plurality of valleys, a second ring having a plurality of peaks and a plurality of valleys, and a connector that connects one of the peaks of the first ring to one of the valleys of the second ring. The connected peak of the first ring includes a deformed portion that extends towards the connected valley of the second ring. The method includes forming a first ring having a plurality of peaks and a plurality of valleys, forming a second ring having a plurality of peaks and a plurality of valleys, deforming a portion of at least one of the peaks of the first ring, and connecting the deformed portion of the peak of the first ring to one of the valleys of the second ring.

Abstract: A stent includes a matrix of struts. The matrix of struts may be disposed parallel to one another in a non-expanded disposition. A plurality of loops along the longitudinal axis may be formed by the matrix of struts. In one aspect, a plurality of cusps in each loop of the plurality of loops connects adjacent struts, the plurality of cusps including tied cusps and free cusps. The tied cusps of one loop can be connected to the tied cusps of an adjacent loop by a bridge extending therebetween. In one aspect, the adjacent struts connected by a tied cusp have different lengths. In one aspect, at least one free cusp in each loop joins two struts of approximately equal length.

Abstract: A stent may include a stent body having a stent axis. The stent body may include structural members defining openings through the stent body. The structural members are provided with regions having different widths. The relative sizes of the widths are selected to control the length of the stent body as the stent body is radially expanded from an undeployed orientation to a deployed orientation. In one embodiment, the regions having different widths are provided by tapering the widths of selected segments of the structural member.

Abstract: A woven, self-expanding stent device has one or more strands and is configured for insertion into an anatomical structure. The device includes a coupling structure secured to two different strand end portions that are substantially aligned with each other. The two different strand end portions include nickel and titanium. The coupling structure is not a strand of the device.

Abstract: A stent comprises at least two or more separated bodies formed by separating in a longitudinal direction a hollow cylindrical body formed by weaving superelastic shape memory alloy wires, the separated bodies connected with each other through an insulator formed of a flexible material, wherein the separated bodies respectively include power connection lines formed by extending the wires from rear sides thereof, and wherein when an electricity generator is connected to the power connection lines of the separated bodies, an electric current flows between the separated bodies to generate electric heat by which the lesion tissue is cauterized.

Abstract: Disclosed is a method of treating a bodily lumen with a stent, the method comprising: disposing a stent within a bodily lumen, the stent comprising a plurality of deformable struts configured to selectively deform in localized regions in the struts upon application of an outward radial force; and expanding the stent by applying the outward radial force, wherein the outward radial force causes selective deformation of the deformable struts in a localized region in the struts.

Abstract: A stent and method comprising inserting within a vessel an unexpanded stent that includes a first zone comprising a plurality of adjacent ring elements, not less than three in number, that are distributed along the stent with a first spacing, and a second zone comprising a plurality of adjacent ring elements that are distributed along the stent with a second spacing, and expanding the stent to cause the plurality of ring elements in the first zone to redistribute to a third spacing that is smaller than the first spacing and to cause ring elements in the second zone to distribute to a fourth spacing larger than the first spacing.

Abstract: A prosthetic apparatus is disclosed including: a tubular stent disposed about a longitudinal axis and extending from a proximal end to a distal end, the stent defining a tubular passage between the ends. The tubular stent has a proximal portion, a distal portion, and a middle portion located between the proximal and distal portions. The proximal and distal portions each comprise a mesh of support struts forming at least one ring of open elements disposed about the longitudinal axis. The middle portion features open regions which reduce or eliminate blockage of sensitive anatomical features at an implantation site.

Abstract: Expandable scaffolds or stents include circumferential elements having a corrugated pattern, which can include a plurality of linear or nonlinear segments. The corrugated pattern distributes stress more uniformly along the circumferential elements, improves radial strength of the scaffolds, reduces acute recoil after deployment, and reduces creep. The scaffolds can be made from a bioabsorbable material.

Abstract: A medical stent includes a stent body defining a longitudinal axis and opposed longitudinal ends, and being adapted to expand from an initial condition to an expanded condition. The stent body includes a plurality of longitudinal cells. The longitudinal cells include opposed end cells and at least one intermediate cell disposed between the end cells. Each longitudinal cell has first and second structural members extending in an undulating pattern about the longitudinal axis. Intermediate connectors interconnect the first and second structural members of the at least one intermediate cell and end connectors interconnecting the first and second structural members of at least one end cell. The number of end connectors is greater than the number of intermediate connectors, and may double the number of end connectors.

Abstract: A stent defining a longitudinal axis is disclosed. A plurality of circumferential support structures are spaced-apart along the longitudinal axis. At least some of the circumferential support structures are interconnected by connection members that extend generally in a circumferential direction.

Abstract: A method for manufacturing a drug-releasing stent is provided. The method includes providing a titanium precursor, a carrier gas and a reactant gas in a plasma vacuum chamber, and generating a plasma for 1 to 6 hours to form a titanium oxide thin film on the surface of a stent. The method further includes providing steam or oxygen and hydrogen in the plasma vacuum chamber and generating a low-temperature plasma for 10 minutes to 2 hours to modify the surface of the titanium oxide thin film. The method further includes reacting the titanium oxide thin film of the stent with a drug in an acidic solution and under an inert gas atmosphere at room temperature to 100° C. for 30 minutes to 4 hours to attach the drug.

Abstract: Some embodiments relate in part to endovascular prostheses and methods of deploying same. Embodiments may be directed more specifically to stent grafts and methods of making and deploying same within the body of a patient. Stent embodiments may include tapered struts for an even distribution of strain. Stent embodiments may also include portions which are enlarged in a circumferential direction which may be configured to stabilize the stent in a constrained state.

Abstract: A system for delivery of a beneficial agent in the form of a viscous liquid or paste allows holes in a medical device to be loaded in a single step process. The loading of a beneficial agent in a paste form also provides the ability to deliver large and potentially sensitive molecules including proteins, enzymes, antibodies, antisense, ribozymes, gene/vector constructs, and cells including endothelial cells.

Abstract: A stent comprised of a valve and a scaffolding structure having components configured to allow at least a portion of the stent to decrease in diameter in response to an axial force applied to the stent. Further, the components and elements of the stent may be configured to balance transverse forces applied to the stent, thus reducing the incidence of infolding.

Abstract: A generally tubular endovascular prosthesis (100) is configured to transition between a radially-compressed state and a radially-expanded state. The prosthesis (100) includes a first generally cylindrical structural portion (101), which has first and second ends (102, 103), and a second generally cylindrical structural portion (104), which has first and second ends (105, 106). The first end (102) of the first structural portion (101) and the first end (105) of the second structural portion (104) meet each other at a juncture (107).

Abstract: Devices, systems, and methods for the prevention of stroke. Devices and systems hereof comprise stents configured to fit within at least part of an artery extending from an aortic arch, and at least one component comprising parallel convex struts for diverting emboli from entering an artery when the component is positioned at or near its ostium. The stents and the deflection component(s) are coupled in a linked configuration. Additionally, a retrieval system is provided, the retrieval system comprising a sleeve catheter and a retrieval device slidably disposed therein. The distal end of the retrieval device comprises an attachment portion configured to engage a device positioned within an artery extending from the aortic arch.

Abstract: A stent having an axial end to which is attached a ring of spoons of a material different from that of the stent. In one aspect, the ring of spoons is connected to the axial end through a plurality of complementary male-female form-fitting portions. In one aspect, the ring of spoons include parallel straight side edges. In one aspect, each of the side edges lies within a first distance from a facing side edge of an adjacent spoon in a stent delivery configuration, and each of the side edges lies within a second distance, greater than the first distance, from the facing side edge of an adjacent spoon in a stent deployed configuration.

Abstract: A drug eluting depot stent is provided. The stent has two free ends and a tubular body connected therebetween. The tubular body includes a series of rings having undulating structures. Each of the undulating structure has a bar arm and a crown connected thereto. The bar arm has a first end portion, a second end portion and a mid-section defined therebetween. The bar arm has opened regions defined at the first end portion, the mid-section, and the second end portion, respectively. The opening ratio of the mid-section is larger than that of the two end portions. With the aforementioned structure, the stress concentration at the crown region can be re-distributed towards the bar arm, and thus effectively prolonging the fatigue life of the stent.

Abstract: A method of percutaneously delivering a multi-layered stent assembly to a desired implantation location of a patient including the steps of radially compressing a multi-layered stent assembly to a compressed size for implantation in a patient, the multi-layered stent assembly including a first stent, a second stent coaxially positioned within at least a portion of a length of the first stent, and a valve, wherein the first stent comprises at least one different material property than the second stent. The method further includes delivering the multi-layered stent assembly to the desired implantation location of the patient using a delivery system and substantially simultaneously expanding the first stent and the second stent of the multi-layered stent assembly at the desired implantation location to a radially expanded size that is larger than the compressed size.

Abstract: An expandable stent comprised of a plurality of helical segments is disclosed. In one embodiment, the stent is generally cylindrical in shape having a cylindrical axis, and comprises a first and second set of helical segments. The helical segments in the first set are substantially parallel and have a first pitch forming a first helical angle with respect to the cylindrical axis. The helical segments in the second set are also generally parallel to each other and form a second pitch that differs from the first pitch, thereby forming a second helical angle with respect to the cylindrical axis. In an alternative embodiment, the stent comprises one set of helical segments and a plurality of circumferential elements that are joined together by the helical segments to form a plurality of cylindrical elements which are joined together to form a stent body. The stent may also have endzones.

Abstract: A stent comprises (a) a first segment that is radially compressible and expandable and (b) a second segment that is substantially rigid in a radial direction. The second segment is bendable to assume a curved configuration while remaining substantially rigid in the radial direction and thereby resisting radial compression and expansion.

Abstract: An expandable stent for implanting in a body lumen, such as a coronary artery, peripheral artery, or other body lumen. In one aspect, the stent includes a butterfly pattern to which connecting links are attached. In another aspect, the stent embodies a non-directional structure. One embodiment is a stent in which one or both ends are more flexible than the center portion. Also, the stent may have a non-uniform drug coating. Another embodiment relates to a stent having ends that are more radiopaque than the center portion.

Abstract: Methods of making a biodegradable polymeric stent made from poly(L-lactide) and a low concentration of L-lactide monomer is disclosed. The concentration of L-lactide is adjusted to provide a degradation behavior that is suitable for different treatment applications including coronary, peripheral, and nasal. Methods include making a poly(L-lactide) material for a stent with uniformly distributed L-lactide monomer through control of polymerization conditions during PLLA synthesis, control of post-processing conditions, or both.

Abstract: A bioabsorbable implant including an elongated metallic element having more than 50% by weight a metal and being substantially free of rare earth elements, the elongated metallic element defining at least a portion of the bioabsorbable implant and including a wire formed into a discrete bioabsorbable expandable metal ring; at least two biostable ring elements, each biostable ring element having a biostable and radio-opaque metallic alloy, the bioabsorbable expandable metal ring being disposed adjacent to at least one of the biostable ring elements; at least one flexible longitudinal connecter including a bioabsorbable polymer, the connector being disposed between at least two adjacent rings; and a coating having at least one pharmaceutically active agent disposed over at least a portion of one ring.

Abstract: A branched stent graft comprises a main body portion and a branch portion. Each of the main body portion and the branch portion includes a stent and a tubular graft. The stent of the main body portion includes a plurality of stent segments, at least one of which is a varying-height stent segment (102). The stent of the branch portion includes one or more stent segments, at least one of which is a varying-height stent segment (103). The distance between the proximal-most stent segment of the branch portion and the main body portion is in the range of 2-8 mm. A positioning ring (105) may be used at a side opening which connects the branch portion and the main body portion, and the positioning ring (105) can be sutured inside the graft of the main body, between the graft of the main body and the graft of the branch, or outside the graft of the branch.

Abstract: A dual lumen catheter may be provided with one or more stents in a stent-deployment lumen and a wire guide disposed through a wire guide lumen. The wire guide may be directed to a target site in a patient body such as a biliary stricture. The catheter may be directed along the wire guide until it is in or adjacent the target site. A distalmost stent may be advanced out a distal side-facing aperture of the stent-deployment lumen into the target site by a pusher member that advances the stent or that holds the stent in place while the catheter is proximally withdrawn from around the stent. With the wire guide remaining substantially in place, the stent-deployment lumen can be reoriented and the steps repeated to place a second (and, if desired, subsequent) stent(s) next to—and generally parallel with—the first stent.

Abstract: Apparatus and methods for delivering prosthetic segments to a body lumen, utilize a device having an elongated flexible member including proximal and distal ends, a plurality of prosthetic segments releasably arranged axially along the elongated flexible member near the distal end and an outer sheath slidably disposed over at least a portion of the prosthetic segments. The apparatus further includes a separator disposed on the outer sheath and adapted to engage the prosthetic segments. The separator is also adapted to be retracted proximally over the prosthetic segments and advanced distally to separate a proximal group of the prosthetic segments from a distal group of the prosthetic segments which are to be deployed in the body lumen.

Abstract: A drug delivery balloon is provided, the a balloon having an outer surface, and a tunable coating disposed on at least a length of the balloon surface. The tunable coating includes a first therapeutic agent and a first excipient, and can include a second therapeutic agent and a second excipient. The first and second therapeutic agents have different dissolution rates during balloon inflation and therefore provide a coating that is tunable.

Abstract: A multi-component endovascular stent-graft system (10) includes a body portion (16), which includes a plurality of stent-grafts (20), which include: (a) respective stent members (22), which are shaped, when the stent-grafts (20) are in respective radially-expanded states, so as to define respective tubes, each of which is circumferentially complete at at least one longitudinal location therealong; and (b) respective graft members (24), which circumscribe respective circumferential arcs (40) of the respective stent members (22). The circumferential arcs (40) have respective extents that are less than entire circumferences of the respective stent members (22) at least partially along respective axial lengths of the stent members (22).

Abstract: A stent graft (1) including a tubular wall (3) with at least one fenestration (40) including a peripheral (37) reinforcement around at least part of the fenestration. There can also be a tubular extension (15). The side arm includes a stent (19) and a cover (17) and extends from and is in fluid communication with the fenestration and the stent graft. The stent may be a self expanding stent. The ring and/or tubular extension provides better support and sealing for an extension arm. The fenestration (40) can be circular or if towards the ends of the stent graft may be in the form of a U-shape (50) with an open end.

Abstract: In embodiments there is described a cardiovascular tube-shaped lockable and expandable bioabsorbable scaffold having a low immunogenicity manufactured from a crystallizable bioabsorbable polymer composition or blend.

Abstract: Disclosed is a method of treating a bodily lumen with a stent, the method comprising: disposing a stent within a bodily lumen, the stent comprising a plurality of deformable struts that are substantially circumferentially aligned and are configured to selectively deform in a circumferential direction in localized regions in the struts upon application of an outward radial force; and expanding the stent by applying the outward radial force, wherein the outward radial force causes selective deformation of the deformable struts in a localized region in the struts.